Repotrectinib 160mg Capsules for ROS1 NSCLC Treatment in India

This is repotrectinib, a treatment that targets ROS1-positive non-small cell lung cancer and NTRK-fusion-positive cancers. It stops TRK, ROS1, and ALK kinases from doing their thing. You get this in 40 mg caps.

For the first 2 weeks, you take 160 mg every day, and then you switch to taking it twice a day. It comes in bottles with 60 capsules each. You can take these with or without food, just swallow them whole.

Just make sure you follow the directions your healthcare provider gives you about using this stuff.